Measles and rubella remain among the most important vaccine-preventable viral infections worldwide despite significant progress in immunization programs. Epidemiological surveillance is a critical component in controlling outbreaks, monitoring disease transmission, and achieving elimination targets. Uzbekistan has implemented comprehensive surveillance systems for measles and rubella in accordance with recommendations of the World Health Organization. The country achieved measles and rubella elimination status in 2017 due to successful vaccination campaigns and enhanced epidemiological monitoring. However, recent increases in measles incidence in Central Asia and neighboring countries have created new epidemiological challenges. This article analyzes the current system of epidemiological surveillance of measles and rubella in Uzbekistan, including laboratory diagnostics, case reporting, immunization strategies, outbreak investigation, and preventive measures. The paper also discusses the role of vaccination coverage, population immunity, molecular epidemiology, and international cooperation in maintaining disease control. Modern surveillance approaches, including laboratory confirmation, integrated information systems, and rapid response mechanisms, are examined in detail. Strengthening immunization programs and improving public awareness remain essential for preventing future outbreaks and sustaining elimination goals.
Epidemiological Surveillance of Measles and Rubella in Uzbekistan
DOI:
Keywords:
Abstract
References
World Health Organization. Manual for the laboratory-based surveillance of measles, rubella, and congenital rubella syndrome. Geneva: WHO; 2018.
World Health Organization Regional Office for Europe. Guidelines for measles and rubella outbreak investigation and response in the WHO European Region. Copenhagen: WHO Europe; 2013.
World Health Organization Regional Office for Europe. Surveillance guidelines for measles, rubella and congenital rubella syndrome in the WHO European Region. Copenhagen: WHO Europe; 2012.
World Health Organization. Eliminating measles and rubella in the WHO European Region: framework for the verification process in 2023 and beyond. Copenhagen: WHO Europe; 2024.
Centers for Disease Control and Prevention. Manual for the Surveillance of Vaccine-Preventable Diseases: Chapter 7 — Measles. Atlanta: CDC; 2025.
Centers for Disease Control and Prevention. Manual for the Surveillance of Vaccine-Preventable Diseases: Chapter 14 — Rubella. Atlanta: CDC; 2025.
Centers for Disease Control and Prevention. Manual for the Surveillance of Vaccine-Preventable Diseases: Chapter 15 — Congenital Rubella Syndrome. Atlanta: CDC; 2026.
O’Connor P., Jankovic D., Muscat M., et al. Measles and rubella elimination in the WHO Region for Europe: progress and challenges. Clinical Microbiology and Infection. 2017;23(8):504–510.
Muscat M., Shefer A., Mamou M., et al. The state of measles and rubella in the WHO European Region, 2013. Clinical Microbiology and Infection. 2014;20(S5):12–18.
Patel M.K., Goodson J.L., Alexander J.P., et al. Progress toward regional measles elimination worldwide, 2000–2023. Weekly Epidemiological Record. World Health Organization; 2024.
World Health Organization. Vaccine Preventable Diseases Surveillance Standards. Geneva: WHO; 2017.
Brady A.M., et al. Serosurveillance for measles and rubella: a systematic review of studies published between 2014 and 2024. Vaccines. 2024;12(7):816.
World Health Organization. Laboratory testing in support of measles and rubella surveillance in elimination settings. Geneva: WHO; 2018.
UNICEF & World Health Organization. Measles cases dropped in Europe and Central Asia in 2025, but outbreak risks remain. 2026.
World Health Organization. Clinical and epidemiological aspects of measles and rubella elimination. Geneva: WHO; 2023.
Gastañaduy P.A., Redd S.B., Fiebelkorn A.P., et al. Measles. In: Manual for the Surveillance of Vaccine-Preventable Diseases. Atlanta: CDC; 2025.
Lanzieri T.M., Redd S.B., Abernathy E., Icenogle J. Congenital Rubella Syndrome. In: Manual for the Surveillance of Vaccine-Preventable Diseases. Atlanta: CDC; 2026.
World Health Organization Regional Office for Europe. Measles and Rubella Monthly Monitoring Reports. Copenhagen: WHO Europe; 2025–2026.
Spika J.S., Hanon F.X., Wassilak S.G.F. Measles and rubella in the World Health Organization European Region. Journal of Infectious Diseases. 2003;187(Suppl 1):S191–S197.
World Health Organization. Global Measles and Rubella Strategic Framework 2021–2030. Geneva: WHO; 2021.